Market Leads & Opportunities

RESEARCH BOARDS: SEP 2020- FUNDING

Source: https://mrc.ukri.org/funding/browse/iib-research-boards/infections-and-immunity-board-iib-research-boards-sep-2020/ 12. Other information: Type: Grants, Researcher-led

1. Title: RESEARCH BOARDS: SEP 2020- FUNDING2. Awarding Authority: Medical Research Council (MRC), Infections and Immunity Board (IIB), GB. Web: 3. Contract type: Service contract4. Description: Research Boards: Sep 2020.The Infections and Immunity Board (IIB) is responsible for the MRC’s investments in infectious human disease and disorders of the human immune system. This includes and is underpinned by fundamental research into human pathogens, as well as the normal development and functioning of the human immune system, which informs mechanism of disease.The Board’s strategy includes extending its global health activities, addressing the challenge of antimicrobial resistance, strengthening pandemic preparedness, investigating immunity and infection through the life course, and supporting data integrative and systems approaches.To deliver its strategy, the Board supports investigator-led grants within its area of remit, and manages a range of strategic investments and partnerships.5. CPV Code(s): 73110000, 73100000, 730000006. NUTS code(s): UKK, UKK1, UKK147. Main site or location of works, main place of delivery or main place of performance: South West (England), Gloucestershire, Wiltshire And Bristol/Bath Area, Swindon.8. Reference attributed by awarding authority: Not provided.9. Estimated value of requirement: Not provided.10. Closing date: 16.9.2020 (16:00:00).11. Address to which they must be sent: For further information regarding the above contract notice please visit:12. Other information: Type: Grants, Researcher-ledTriage/shortlisting: Jan 2021Meeting date: 24 – 25 Feb 2021Categories: Infections and immunityYou can apply to the Infections and Immunity Board through the following grant schemes:Research grantProgramme grantNew investigator research grantPartnership grant# funding opportunity# COVID-19